NOALKOGOL JIGAR YOG'LI KASALLIGINING TURLI KLINIK SHAKLLARIDA QON ZARDOBIDAGI SERAMID DARAJASINING QIYOSIY TAHLILI
Vol. 5 No. 16 (2026): Applied Sciences in the Modern World 61-62
Abstract
Noalkogol jigar yog'li kasalligi (NJYK) jahon aholisining taxminan chorak qismini qamrab olgan surunkali gepatologik patologiya bo'lib, Markaziy Osiyo mintaqasi uning eng tez tarqalayotgan hududlaridan biri hisoblanadi. Kasallikning uzoq muddat klinik belgilarsiz kechishi va tashxis ko'pincha fibroz shakllangan bosqichda qo'yilishi erta aniqlash muammosini birinchi darajali vazifaga aylantiradi. So'nggi yillarda NJYK patogenezida sfingolipidlar sinfiga mansub bioaktiv lipid — seramidning gepatotsitlarda lipid to'planishi, insulin qarshiligi va apoptoz jarayonlaridagi ishtiroki faol o'rganilmoqda, ammo uning kasallikning turli klinik shakllaridagi o'zgarish darajasi yetarlicha aniqlanmagan.
References
Younossi Z.M., Golabi P., Paik J.M., Henry A., Van Dongen C., Henry L. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: a systematic review // Hepatology. – 2023. – Vol. 77, №4. – P. 1335–1347.
Pagadala M., Kasumov T., McCullough A.J., Zein N.N., Kirwan J.P. Role of ceramides in nonalcoholic fatty liver disease // Trends in Endocrinology and Metabolism. – 2012. – Vol. 23, №8. – P. 365–371.
Luukkonen P.K., Zhou Y., Sädevirta S. et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease // Journal of Hepatology. – 2016. – Vol. 64, №5. – P. 1167–1175.
Wasilewska N., Bobrus-Chociej A., Harasim-Symbor E. et al. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease // Lipids in Health and Disease. – 2018. – Vol. 17. – Article 216.
Ooi G.J., Meikle P.J., Huynh K. et al. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis // Journal of Hepatology. – 2021. – Vol. 75, №3. – P. 524–535.
Denimal D., Béland-Bonenfant S., Pais-de-Barros J.P. et al. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes // Cardiovascular Diabetology. – 2023. – Vol. 22. – Article 310.
Readership
Downloads
Published
Issue
Section
How to Cite
